Type 1 diabetes immunotherapy using polyclonal regulatory T cells
University of California, San Francisco · Benaroya Research Institute · +3 more institutions
Indexed incrossref
Abstract
Autologous regulatory T cells can be expanded and are well tolerated in patients with recent-onset type 1 diabetes.
Citation impact
1,008
total citations
- FWCI
- 56.86
- Percentile
- 100%
- References
- 44
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Immunotherapy
- Polyclonal antibodies
- Type 2 diabetes
- Diabetes mellitus
- Medicine
- Type 1 diabetes
- Regulatory T cell
- Immunology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.